U.S. Warns Chinese Exporters Could Be Banned For Poor Drug Products
This article was originally published in PharmAsia News
Executive Summary
Chinese companies that export products to the United States could have their drug products barred if they fail to meet U.S. standards. Michael Leavitt, secretary of Health and Human Services, acknowledged during a visit to Beijing his country could not inspect everything imported into the United States, so it must rely on market forces to punish companies and countries that fail to meet product-quality certification standards. In his talks with officials, Leavitt seeks to close a loophole in Chinese regulations that allows ingredients for drugs to be produced without being inspected. (Click here for more - a subscription may be required